Federation des caisses Desjardins du Quebec’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-100
Closed -$3.48K – 2549
2021
Q4
$3.48K Hold
100
– – ﹤0.01% 2281
2021
Q3
$2.71K Hold
100
– – ﹤0.01% 2370
2021
Q2
$2.59K Hold
100
– – ﹤0.01% 2373
2021
Q1
$2.15K Hold
100
– – ﹤0.01% 2322
2020
Q4
$2.15K Hold
100
– – ﹤0.01% 2192
2020
Q3
$1.48K Buy
+100
New +$1.8K ﹤0.01% 2026
2020
Q1
– Sell
-500
Closed -$8.13K – 2225
2019
Q4
$8.13K Buy
+500
New +$11.8K ﹤0.01% 1934

Other funds holding ANAB

Federation des caisses Desjardins du Quebec's ANAB Position: Q1 2022 in Review

Federation des caisses Desjardins du Quebec sold out of AnaptysBio (ANAB) in Q1 2022, closing a stake of 100 shares — an estimated $3.48K sold.

Federation des caisses Desjardins du Quebec first reported a position in ANAB in Q4 2019 and held it in 7 quarters. The position peaked at $8.13K in Q4 2019. 132 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.

  • Federation des caisses Desjardins du Quebec reported no remaining AnaptysBio position as of Q1 2022 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 100 AnaptysBio shares in Q1 2022, an estimated $3.48K.
  • Federation des caisses Desjardins du Quebec first reported a position in AnaptysBio in Q4 2019 and held it in 7 quarters.
  • Federation des caisses Desjardins du Quebec's AnaptysBio position peaked at $8.13K in Q4 2019.
  • 132 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2022, filed 15 Aug 2024.